Operator Good day, ladies and gentlemen, and welcome to the Exelixis fourth quarter and fiscal year 2024 financial results ...

Q4 2024 Earnings Call Transcript February 13, 2025 PPL Corporation misses on earnings expectations. Reported EPS is $0.34 EPS ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ETCompany ParticipantsJesse Rose - Head of Investor ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

If you have a company that imports chemicals – whether they are used as raw materials or components for onward manufacturing, ...

On Jan. 24, village mayor Michael J. Zagrobelny was in his vehicle heading south, doing a task he probably never thought ...

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

With this series of weekly updates, WOLA seeks to cover the most important developments at the U.S.-Mexico border. See ...

Q4 2024 Results Conference Call February 11, 2025 4:00 AM ETCompany ParticipantsIngela Ulfves - Head of Investor ...

Blaize's innovative product pipeline, built on its full-stack programmable processor architecture suite and software platform for AI processing, has resulted in an increasingly robust and growing ...

As new sea passages open up, the commercial and defence possibilities are becoming irresistible. To take advantage, America desperately needs ships ...